
|Articles|May 1, 2001
Combination therapy cost-effective for treating severe onychomycosis
Washington - In patients with severe toenail onychomycosis, combination topical and systemic antifungal therapy - consisting of locally applied amorolfine 5 percent nail lacquer plus oral terbinafine or itraconazole - improves response rates and is more cost-effective compared with oral treatment alone, according to research presented at the annual meeting of the American Academy of Dermatology.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Envudeucitinib Achieves 54% PASI 100 Rate at 48 Weeks in Phase 3 Extension
2
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
3
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
4
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
5











